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Abstract
Background
The Scottish Cervical Screening Programme currently offers three-yearly 
screening to all women between the ages of 20 and 60.  However, previous 
studies have indicated that well-screened women over the age of 50 are likely to 
be at low risk of cervical neoplasia.  This study aimed to explore the implications 
of discharging these women from screening in a typical area of Scotland.
Methods
1. Case-control study of the screening histories of women with and without 
screen-detected cervical neoplasia between ages 50 and 59 in Lanarkshire.
2. Cross-sectional study of the prevalence of adequate screening histories among 
women currently aged 50 in Lanarkshire.
3. Use of routine screening programme statistics to estimate the effects of 
introducing an early discharge policy.
Results
1. Women reaching the age of 50 with two recent, consecutive, negative smears 
had reduced odds of screen-detected neoplasia in the subsequent decade.
2. The estimated odds ratio for all screen-detected neoplasia (CIN 1-3, 
adenocarcinoma in situ and invasive carcinoma) was 4.4 (95% confidence interval 
1.6-13.2, p=0.002).
3. The estimated odds ratio for screen-detected high-grade CIN and invasive 
squamous carcinoma was 17.0 (95% confidence interval 2.4-243.0, p=0.0004).
4. 54.0% (95% confidence interval 47.9%-59.9%) of screening participants 
currently aged 50 fulfilled the definition of adequate screening.
5. Discharging these women might be expected to reduce screening workload by 
approximately 10%, but those discharged would be at increased risk of neoplasia.
Conclusion
Now that full screening histories are available in all health board areas since 
1990, the identification of a low-risk group within the screened population could 
be the first step towards a screening programme targeted more closely on those 
with the greatest capacity to benefit.
Introduction
The Scottish Cervical Screening Programme currently offers cervical screening to 
all women aged between 20 and 60 at three-yearly intervals.  Cervical cancer 
incidence and mortality have fallen since the introduction of the programme, but 
some have argued that this has been achieved at the expense of investigating 
and treating large numbers of women needlessly.  In other words, the 
programme has achieved high sensitivity at the cost of low specificity. [1]  This 
arises partly from an inability to distinguish lesions which may regress from those 
which will progress to malignancy, and partly from the practice of offering  
screening to all women in the specified age range, irrespective of their underlying 
risk of disease.  
The 1997 Guidelines for clinical practice and programme management therefore 
recommended that consideration be given to identifying low-risk women and 
discharging them from screening.  This would be expected to benefit the women, 
who would avoid several smear tests, and to improve the efficiency of the 
programme. [1]
In an area with an established screening programme, there will be a group of 
older women who have accumulated a series of negative cervical smears.  These 
well-screened women are unlikely to have cervical intraepithelial neoplasia (CIN), 
a precursor of invasive cancer, which is in any case commoner in younger 
women. [2]  Older women may also be less likely to harbour cervical infection 
with high-risk types of the human papillomavirus (HPV), an important 
determinant of cervical neoplasia, and less likely to be exposed to the virus 
through multiple sexual partners. [3,4,5]
Case-analysis studies in Tayside and Grampian have found that few of the women 
developing cervical neoplasia after the age of 50 have been adequately screened 
prior to age 50.  The authors of these studies have therefore suggested that 
adequately-screened women might be discharged from screening from the age of 
50. [6,7,8,9]  In addition, cohort studies in Nordic populations have shown that 
detection rates for CIN fall with increasing age, and with the number of previous 
negative smears.  In one cohort of 5893 women with three negative smears 
before 50 and one negative smear after 50, only 9 cases of in situ or invasive 
cancer occurred in the following decade. [10,11]  
Sherlaw-Johnson et al have modelled the effects of reducing the upper age limit 
for screening in England.  The withdrawal of women from age 50 following four 
consecutive negative smears was predicted to reduce smear test and colposcopy 
workload substantially, but at the cost of two additional cases of invasive cancer 
per 100,000 women per year. [12]
The observational studies to date have been performed in areas which were early 
adopters of population-based screening and centralised record-keeping.  Their 
methods and findings cannot necessarily be generalised.  Therefore, this study 
aimed to investigate the association between screening history and the 
subsequent risk of screen-detected disease, using routinely-available records in a 
typical area of Scotland, and to explore the implications of different possible 
criteria for discharge from screening.
Methods
The research comprised a case-control study and a cross-sectional study, 
supplemented by an examination of routine screening programme statistics.  
Approval was granted by the Lanarkshire Ethics of Research Committee.
Case-control study
Subjects
Cases comprised all women with a histopathological diagnosis of cervical 
intraepithelial neoplasia (CIN) or cervical cancer, made following a smear (index 
smear) taken between the ages of 50 and 59 and during the period 1995-1999,  
and processed at Monklands Hospital, the only cervical cytology laboratory in 
Lanarkshire.  
Cases were ascertained from the Pinnacle database at Monklands Hospital, which 
contains all biopsy results from Monklands, and notifications of biopsies 
performed at the other colposcopy clinics in Lanarkshire.  Cases without an 
identifiable index smear were assumed to have presented clinically and were 
excluded from the study.  The possibility that some index smears were taken 
during the investigation of a symptomatic cancer cannot be excluded.
A matched control for each case was obtained by identifying the first negative 
smear reported on the same, or next, day from a woman of the same age.
Exposure
Each woman’s screening history since the age of 40 was categorised according to 
four alternative definitions of adequate screening, based upon those used in 
previous published studies (Table 1). [6,8,9]  An interval of two to four years 
between smears was deemed acceptable, to allow for women who may have 
missed initial appointments or been subject to delays in recall.  A screening 
history was still categorised as adequate if there were additional negative smears 
between those which met the interval criteria.
Each woman’s screening history was initially ascertained from the cytology 
database.  However, computerised cytology records in Lanarkshire are incomplete 
prior to 1990.  Therefore, additional earlier smear results were sought where 
necessary, first from the call/recall database, and then from the woman’s general 
practitioner (GP).
Cross-sectional study
The call/recall database was searched by date of birth to identify a birth cohort of 
all women born in January 1950 and currently eligible for screening in 
Lanarkshire.  The screening history for each woman was obtained from her 
call/recall record, and categorised according to the different definitions of
adequacy (Table 1).
Screening programme statistics
The age structures of (i) the population of women eligible for screening in 
Lanarkshire, and (ii) the population of women screened within the last year in 
Lanarkshire, were obtained from the routine statistical return ISD(D)4 for the 
year ending 31 March 2000 (Information Services, Lanarkshire Health Board).
Analysis
The distribution of diagnoses among the cases, and the proportions of cases and 
controls fulfilling the various definitions of adequate screening, were analysed 
using Minitab.  
A matched case-control analysis was then carried out, using each definition of 
adequate screening in turn as the exposure variable.  For each 2x2 table, the 
odds ratio was estimated, the null hypothesis of no association was tested using 
McNemar’s continuity-corrected chi-squared (X2) statistic, and a 95% confidence 
interval was calculated using the Normal approximation to the Binomial 
distribution, all using Epi Info.  
For one 2x2 table (D) in which the sum of the discordant pairs was less than 10, 
the 95% confidence interval was calculated using the exact Binomial method. 
[13]
The dataset was then partitioned to exclude cases of CIN 1, adenocarcinoma in 
situ and adenocarcinoma.  This left cases of high-grade squamous neoplasia (CIN 
2, CIN 3 and squamous carcinoma), the most important disease states cervical 
screening can be expected to detect.  A matched case-control analysis of the 
association of high-grade squamous neoplasia with adequacy definition A was 
carried out as described above.
95% confidence intervals for the proportions of women with adequate screening 
histories in the cross-sectional study were calculated using Minitab. 
Population attributable risk (PAR) fractions were estimated using the expression 
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where p represents the estimated population prevalence of inadequate screening 
from the cross-sectional study, and R, the relative risk, is approximated by the 
estimated odds ratio from the case-control study. [14]
In order to estimate the potential effects of an early discharge policy on screening 
workload, it was assumed that the proportion adequately screened in the current 
50-year-old cohort could be applied as an average to the entire 50-60 age group.
Results
Case-control study
75 cases and matched controls were identified.  The distribution of diagnoses 
among the cases is shown in Figure 1.  CIN 3 accounted for approximately half of 
the cases; there were few invasive cancers. 
Data from the cytology and call/recall databases were sufficient to determine the 
exposure history for only 43 (29%) women.  GPs returned data for 95 (89%) of 
the remaining 107 women.  Overall, complete categorisation of exposure was 
possible for 64 (85%) of the matched pairs.
The numbers and proportions of cases and controls whose screening histories 
fulfilled the different definitions of adequacy are shown in Table 2.  13/69 (19%) 
of cases fulfilled at least one definition of adequate screening.  CIN 1 and 
glandular lesions accounted for 8/13 (62%) of these adequately-screened cases, 
compared with 18/75 (24%) of cases in total.
The results of the matched analysis of the exposure patterns of case-control pairs 
for each definition of adequate screening are shown in Table 3.
Cross-sectional study
Of 278 women eligible for screening, 150 had had two consecutive negative 
smears prior to age 50 (54.0%; 95% confidence interval 47.9%-59.9%).  113 
had had three consecutive negative smears (40.6%; 95% confidence interval 
34.8%-46.7%). 
Table 4 shows the estimated reduction in screening workload associated with the 
early discharge of women with two, or three, consecutive negative smears.
Calculation of the population attributable risk fractions (Table 5) estimated that 
61% of all screen-detected neoplasia, and 88% of screen-detected high-grade 
squamous neoplasia, in the 50-59 age group was attributable to inadequate 
screening, as defined as the absence of two consecutive negative smears prior to 
age 50.
Discussion
Study design
This is the first UK study to use the case-control method to explore the 
implications of the early withdrawal of adequately-screened women from cervical 
screening.  A retrospective cohort study would have been the design of choice for 
this study, but this would have depended upon comprehensive centralised 
screening records, established since the women were aged 40.  Such records did 
not exist in Lanarkshire prior to 1990.  A case-control approach was therefore 
adopted, despite its well-known hazards of bias and confounding.  Controls were 
matched for screening participation in order to minimise selection bias, and any 
possible response bias was mitigated by the high response rate from GPs.  
Migration bias, arising from women having had additional smears processed in 
other laboratories, cannot be discounted, but this is likely to have affected cases 
and controls equally and only in small numbers.
Implications of findings
Most women with screen-detected cervical neoplasia between the ages of 50 and 
59 had not been adequately screened, by any definition, prior to the age of 50. In 
previous Scottish studies, even smaller proportions of cases had been adequately 
screened: 0% of Tayside cases had had two negative smears, and 2.7% of 
Grampian cases had had three negative smears. [6,8]
An estimated 54% of women currently aged 50 in the Lanarkshire screening 
programme have accumulated two consecutive negative smears; 41% have 
accumulated three.  In Grampian, Cruickshank et al estimated that 83% of 
women aged 49 and 50 met the criterion of two negative smears [8].  This 
strengthens the impression that women in an area with a longer history of 
organised screening, such as Grampian, are much more likely to have acquired an 
adequate screening history.  
For a woman who reaches the age of 50 with two recent consecutive negative 
smears, the odds of developing screen-detected neoplasia in the next decade are 
an estimated 4.4 times smaller than the odds for other screening participants of 
the same age.  In the exploratory analysis of the subgroup of high-grade 
squamous cases, the estimated odds ratio was substantially higher at 17.  
Although the confidence intervals for these estimates are wide, reflecting the 
relatively small size of the study, these differences are highly unlikely to have 
been observed by chance.
The estimated odds ratios for the more stringent definitions of adequate 
screening (B, C and D) did not differ significantly from unity.  This may reflect the 
unexpectedly small proportions of control women who fulfilled these criteria.  A 
retrospective power calculation showed that the study was under-powered to 
detect an odds ratio of 4.4 or greater for these exposure variables; adequate 
testing of the hypothesis for all exposure variables would require a substantially 
larger study.
Discharging women with two negative smears at age 50 might be expected to 
reduce the total number of women being screened in Lanarkshire by 
approximately 4000 (10%) per annum; if three negative smears were required 
for discharge, the corresponding reduction would be approximately 3000 (7.5%) 
per annum.  These estimates are considerably lower than the anticipated saving 
of “up to 18% of smear tests” from Tayside. [6] 
The population attributable risk calculations, which depend upon necessarily 
imprecise odds ratio estimates, indicate that an estimated 39% of all cervical 
neoplasia, and 12% of all high-grade squamous neoplasia, detected by screening 
women aged 50-59 is not attributable to prior inadequate screening.  Adequately-
screened women discharged at age 50 would be at increased risk from disease –
predominantly CIN 1 and glandular lesions - which is currently being detected by 
screening them beyond the age of 50.  This is in keeping with the predictions of 
Sherlaw-Johnson et al. [12]
This study has therefore confirmed that adequately-screened women reaching the 
age of 50 are at substantially reduced risk of screen-detected neoplasia, but the 
projected benefits to the screening programme of discharging these women are 
less than those implied by previous studies.  This partly reflects the lower 
proportion of women in Lanarkshire who have been adequately screened, but 
may also reflect the fact that the women in this study were drawn from a more 
recent birth cohort.  They may therefore have a higher underlying risk of cervical 
neoplasia than the women studied in Tayside and Grampian.
A new approach to cervical screening?
Cervical screening is currently offered to a large population of women whose need 
for screening is assumed to be homogeneous.  Apart from the follow-up of 
abnormal results, no account is taken of previous screening history in planning 
the recall of individual women.  Other identified risk factors for cervical cancer 
play no significant part in the definition of the need for screening.
This study has confirmed that a group of low-risk older women can be identified 
within the cervical screening target population on the basis of their recorded 
screening histories.  It may be possible to show, in a larger study, that women 
meeting more stringent criteria are at even lower risk.  The identification of this 
low-risk group is an example of how epidemiological data might be used to inform 
a different approach to population screening.
A utilitarian approach would redefine target groups for screening, seeking to 
maximise programme efficiency by targeting screening on women with the 
greatest capacity to benefit.  Many women might welcome the opportunity to be 
discharged from screening if they understood themselves to be at low risk, but 
others might jealously guard the peace of mind conferred by “unnecessary” 
negative results.  Further research might explore women’s views on what level of 
disease risk justifies screening, and attitudes to a possible re-targeting of the 
programme.  Age and screening history are particularly suitable as criteria for 
targeted screening, as the necessary information is already available in call/recall 
databases.  Additional variables such as HPV status might also be used, in time, 
to target screening provided suitable estimates of risk were available.
A more radical, empowering alternative would be to use risk data as a starting 
point for a participative assessment of an individual woman’s need for screening.  
Such an approach is already recommended, for example, in determining the need 
for screening for hyperlipidaemia, and would be consistent with the recent report 
from the National Screening Committee. [15,16]  This might appear threatening, 
not only to professionals, but also to those women who would prefer not to 
confront the uncertainty associated with screening.  Although a participative 
approach would require additional training and consultation time, these costs 
might be justified by a reduction in the number of low-yield smears and the 
benefits of placing cervical screening within a more holistic, empowering 
reproductive health consultation.  Further research might explore the extent to 
which women wish to be involved in decision-making in cervical screening, how 
best to provide the required information, and whether this would promote uptake 
among high-risk women - or simply suppress uptake among low-risk women.
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Table 1 Definitions of adequate screening
Variable Possible values Negative smears*
before age 50
Negative smears*
at or after age 50
A Yes/No 2 0
B Yes/No 2 1
C Yes/No 3 0
D Yes/No 3 1
*Consecutive negative smears at intervals of between two and four years
Figure 1 Diagnoses of cases
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Table 2 Proportions of subjects with a history of adequate screening
Definition of 
adequate screening
Cases fulfilling definition Controls fulfilling definition
A 13/69 (19%) 32/70 (46%)
B 7/69 (10%) 7/72 (10%)
C 7/69 (10%) 11/69 (16%)
D 4/69 (6%) 3/72 (4%)
Table 3 Case-control comparisons
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Table 4 Estimated effects on screening workload
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Table 5 Estimated population attributable risk fractions
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